J&J ob­jects to Sanofi’s '#1 Doc­tor Rec­om­mend­ed' claims about heart­burn drug Zan­tac

French drug mak­er Sanofi has come un­der the scan­ner of the non­prof­it Na­tion­al Ad­ver­tis­ing Di­vi­sion (NAD) af­ter its arch-ri­val John­son & John­son com­plained about the com­pa­ny’s mis­lead­ing ad­ver­tis­ing claims.

Sanofi has been asked to aban­don claims that its over-the-counter drug Zan­tac 360° is the “#1 Doc­tor Rec­om­mend­ed” for heart­burn.

Zan­tac, a ver­sion of which was pulled from shelves in the US by GSK in 2019 due to im­pu­ri­ties, is an H2 block­er that stops the se­cre­tion of gas­tric acid and is loaded with an ac­tive in­gre­di­ent called famo­ti­dine. It is rec­om­mend­ed for mild to mod­er­ate heart­burn and in­di­ges­tion.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER